Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-03

Clinical Trial Update: Evaluation of Ocoxin®-Viusid® in Breast Cancer [Phase 2]

View source ↗

Summary

The trial update reports completion of a Phase 2 study evaluating Ocoxin-Viusid in breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ocoxin®-Viusid®

Snippet

Sponsor: Catalysis SL | Conditions: Breast Cancer, Breast Carcinoma | Phase 2 | Status: COMPLETED